PROFESSOR ISRAEL VLODAVSKY TO BE APPOINTED ICRF PROFESSOR
Professor Israel Vlodavsky
29 August, 2007
The ICRF (Israel Cancer Research Fund), a North American organization, solely devoted to supporting cancer research in Israel announced the awarding of one of its Professorships to Professor Israel Vlodavsky of the Rappaport Institute. Since its founding in 1975, the ICRF, a major contributor to Cancer research in Israel has provided 1,628 grants, including 3 Professorships to date, and 3 additional professorships this year, to outstanding Israeli cancer researchers. Many achievements and breakthroughs have been achieved because of the assistance of the ICRF. Two other Rappaport Institute Professors, Avram Hershko and Aaron Ciechanover are also recipients of ICRF Professorships. Professors Hershko and Ciechanover were awarded the 2004 Nobel Prize in Chemistry for their discovery of the ubiquitin system, which led to a groundbreaking new treatment for multiple myeloma, a cancer of the bone marrow.
Professor Vlodavsky (Cancer and Vascular Biology Research Center, The Rappaport Faculty of Medicine, Technion) is listed as the author of 345 scientific papers and review articles, 130 invited lectures in international conferences, and an inventor in 24 patents and 22 patent applications which are pending. His research focuses on Cancer metastasis and angiogenesis and on cell interaction with the tumor microenvironment. His studies on Heparanase, a unique human enzyme playing a key role in cancer progression, have helped pave the way for the development of anti-heparanase agents, expected to play an important role in the fight against cancer.